Clinical Commentary: Managing Adverse Events From PARP Inhibitors in Advanced Ovarian Cancer - Targeted Oncology
At a live virtual event, Saketh Guntupalli, MD, discussed
with participants the role of PARP inhibitors in the first-line
setting for patients with advanced ovarian cancer.
EVENT SUMMARY
At a live virtual event, Saketh Guntupalli, MD, discussed with participants the role of PARP inhibitors in the first-line setting for patients with advanced ovarian cancer. Looking at … [+11179 chars]
Read More
Other Stories in Health
- Dosa saree, Idli shirt and a pani puri watch? AI turns desi food into fashion
- Where and why men die younger: global data breaks it down
- 8 Best Foldable Rowing Machines, According to Editors and Certified Trainers
- Strawberry Lemon Cream Crepes {Grain-Free Options Included}
- What predicts belief in the afterlife? A massive global study has answers
- Getting active in midlife may boost brain resilience to Alzheimer’s
- May 2025 Cooking Challenge
- May 2025 Cooking Challenge
- TDP-43 dysfunction in brain blood vessels may drive Alzheimer's and ALS progression
.png)
